In this blog post we will debunk some of the most common myths associated with GLP-1 agonists for weight loss, providing clarity and insight into how these treatments really work
This contributed to a higher discontinuation rate for tirzepatide (13.2% vs 10.1%)
The management approach is the same regardless of which drug
Moreover, we show BB is the major gut microbial metabolite formed from dietary L -carnitine in mice, and like dietary L -carnitine, in a gut microbiota-dependent manner is converted into TMA and TMAO, and accelerates atherosclerosis
A higher proportion reached clinically meaningful weight-loss thresholds, with greater improvements in cardiometabolic markers
Anyone with specific metabolic health concerns should consult with a healthcare provider about appropriate options, which may include prescription medications where clinically indicated